Literature DB >> 21284530

Autoinflammatory diseases and cardiovascular manifestations.

Donato Rigante1, Luca Cantarini, Massimo Imazio, Orso Maria Lucherini, Emanuela Sacco, Mauro Galeazzi, Maria Giuseppina Brizi, Antonio Brucato.   

Abstract

Abstract A host of clinical scenarios can be depicted in hereditary autoinflammatory diseases, and the cardiovascular system can also be involved especially in familial Mediterranean fever (FMF), caused by mutations in the MEFV gene, and tumour necrosis factor receptor-associated periodic syndrome (TRAPS), caused by mutations in the TNFRSF1A gene. Pericardial diseases are the most represented cardiovascular abnormalities, though the role of MEFV and TNFRSF1A in the initiation of heart involvement has not been demonstrated formally and will be discussed herein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21284530     DOI: 10.3109/07853890.2010.547212

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  28 in total

Review 1.  Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.

Authors:  Massimo Imazio; Yehuda Adler
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 2.  Lights and shadows in autoinflammatory syndromes from the childhood and adulthood perspective.

Authors:  Donato Rigante; Antonio Vitale; Marco Francesco Natale; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-12-03       Impact factor: 2.980

3.  Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.

Authors:  Luca Cantarini; Orso Maria Lucherini; Antonio Brucato; Luca Barone; Davide Cumetti; Francesca Iacoponi; Donato Rigante; Giovanni Brambilla; Silvana Penco; Maria Giuseppina Brizi; Maria Cristina Patrosso; Guido Valesini; Bruno Frediani; Mauro Galeazzi; Rolando Cimaz; Giuseppe Paolazzi; Antonio Vitale; Massimo Imazio
Journal:  Clin Res Cardiol       Date:  2012-02-05       Impact factor: 5.460

4.  A possible still role for colchicine in children with idiopathic recurrent acute pericarditis?

Authors:  Giusyda Tarantino; Angelica Bibiana Delogu; Gabriella De Rosa; Donato Rigante
Journal:  Intern Emerg Med       Date:  2018-12-05       Impact factor: 3.397

Review 5.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

Review 6.  Cardiovascular disease in patients with autoinflammatory syndromes.

Authors:  Rainer Hintenberger; Agnes Falkinger; Kathrin Danninger; Herwig Pieringer
Journal:  Rheumatol Int       Date:  2017-11-01       Impact factor: 2.631

Review 7.  Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Donato Rigante; Giuseppe Lopalco; Antonio Vitale; Orso Maria Lucherini; Caterina De Clemente; Francesco Caso; Giacomo Emmi; Luisa Costa; Elena Silvestri; Laura Andreozzi; Florenzo Iannone; Mauro Galeazzi; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

Review 8.  A Comprehensive Overview of the Hereditary Periodic Fever Syndromes.

Authors:  Donato Rigante; Bruno Frediani; Luca Cantarini
Journal:  Clin Rev Allergy Immunol       Date:  2018-06       Impact factor: 8.667

Review 9.  Cardiac disease in familial Mediterranean fever.

Authors:  Eren Erken; Ertugrul Erken
Journal:  Rheumatol Int       Date:  2017-10-20       Impact factor: 2.631

Review 10.  Systemic and organ involvement in monogenic autoinflammatory disorders: a global review filtered through internists' lens.

Authors:  Marco Cattalini; Martina Soliani; Giuseppe Lopalco; Donato Rigante; Luca Cantarini
Journal:  Intern Emerg Med       Date:  2016-05-25       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.